Published in N Engl J Med on January 17, 2008
Effects of Polyphenols on Iron Absorption in Iron Overload Disorders. (POLYFER) | NCT03453918
Clinical assessment incorporating a personal genome. Lancet (2010) 10.18
Forging a field: the golden age of iron biology. Blood (2008) 3.83
Exome sequencing in HFE C282Y homozygous men with extreme phenotypes identifies a GNPAT variant associated with severe iron overload. Hepatology (2015) 3.40
Return of individual research results from genome-wide association studies: experience of the Electronic Medical Records and Genomics (eMERGE) Network. Genet Med (2012) 3.29
Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J Hepatol (2010) 2.82
Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest (2011) 2.36
Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology (2011) 2.28
Elevated serum ferritin. JAMA (2014) 2.04
HFE C282Y homozygotes are at increased risk of breast and colorectal cancer. Hepatology (2010) 1.76
Genetic testing and common disorders in a public health framework: how to assess relevance and possibilities. Background Document to the ESHG recommendations on genetic testing and common disorders. Eur J Hum Genet (2011) 1.57
Impact of hemochromatosis gene (HFE) mutations on epithelial ovarian cancer risk and prognosis. Int J Cancer (2011) 1.52
Ferritin for the clinician. Blood Rev (2008) 1.46
Total mortality by elevated transferrin saturation in patients with diabetes. Diabetes Care (2013) 1.43
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets (2012) 1.23
Iron homeostasis: recently identified proteins provide insight into novel control mechanisms. J Biol Chem (2008) 1.22
HFE C282Y homozygotes have reduced low-density lipoprotein cholesterol: the Atherosclerosis Risk in Communities (ARIC) Study. Transl Res (2008) 1.20
Clinical manifestations of hemochromatosis in HFE C282Y homozygotes identified by screening. Can J Gastroenterol (2008) 1.19
Novel association to the proprotein convertase PCSK7 gene locus revealed by analysing soluble transferrin receptor (sTfR) levels. Hum Mol Genet (2010) 1.18
Genetic mechanisms and modifying factors in hereditary hemochromatosis. Nat Rev Gastroenterol Hepatol (2009) 1.10
HFE C282Y/H63D compound heterozygotes are at low risk of hemochromatosis-related morbidity. Hepatology (2009) 1.07
Impact of gene patents and licensing practices on access to genetic testing for hereditary hemochromatosis. Genet Med (2010) 1.07
Iron overload is rare in patients homozygous for the H63D mutation. Can J Gastroenterol Hepatol (2014) 1.04
A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis. Br J Haematol (2009) 1.00
Factors influencing disease phenotype and penetrance in HFE haemochromatosis. Hum Genet (2010) 0.97
Quantification of iron concentration in the liver by MRI. Insights Imaging (2011) 0.96
Iron levels in hepatocytes and portal tract cells predict progression and outcomes of patients with advanced chronic hepatitis C. Gastroenterology (2011) 0.95
Liver disease in women: the influence of gender on epidemiology, natural history, and patient outcomes. Gastroenterol Hepatol (N Y) (2013) 0.94
Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations. Hepatology (2012) 0.93
Clinical penetrance of hereditary hemochromatosis. N Engl J Med (2008) 0.92
Penetrance of NOD2/CARD15 genetic variants in the general population. CMAJ (2010) 0.92
Cardiac ferroportin regulates cellular iron homeostasis and is important for cardiac function. Proc Natl Acad Sci U S A (2015) 0.91
Bacterial cell wall constituents induce hepcidin expression in macrophages through MyD88 signaling. Inflammation (2012) 0.91
Points to consider in assessing and appraising predictive genetic tests. J Community Genet (2010) 0.91
Hereditary hemochromatosis and diabetes mellitus: implications for clinical practice. Nat Rev Endocrinol (2010) 0.90
Management of transfusional iron overload - differential properties and efficacy of iron chelating agents. J Blood Med (2011) 0.90
Association between C282Y and H63D mutations of the HFE gene with hepatocellular carcinoma in European populations: a meta-analysis. J Exp Clin Cancer Res (2010) 0.90
Iron overload in HFE C282Y heterozygotes at first genetic testing: a strategy for identifying rare HFE variants. Haematologica (2011) 0.90
A new 500 kb haplotype associated with high CD8+ T-lymphocyte numbers predicts a less severe expression of hereditary hemochromatosis. BMC Med Genet (2008) 0.89
HFE Cys282Tyr homozygotes with serum ferritin concentrations below 1000 microg/L are at low risk of hemochromatosis. Hepatology (2010) 0.89
Stimulation of proliferation in the colorectal mucosa by gastrin precursors is blocked by desferrioxamine. Am J Physiol Gastrointest Liver Physiol (2010) 0.89
Genetic tests: clinical validity and clinical utility. Curr Protoc Hum Genet (2014) 0.88
A phase 1/2, dose-escalation trial of deferasirox for the treatment of iron overload in HFE-related hereditary hemochromatosis. Hepatology (2010) 0.88
The global burden of iron overload. Hepatol Int (2009) 0.87
Hereditary hemochromatosis in the post-HFE era. Hepatology (2008) 0.87
Metabolic crosstalk between host and pathogen: sensing, adapting and competing. Nat Rev Microbiol (2016) 0.87
Gastrins, iron homeostasis and colorectal cancer. Biochim Biophys Acta (2011) 0.86
Down-regulation of hepcidin in porphyria cutanea tarda. Blood (2008) 0.86
In silico QTL mapping of basal liver iron levels in inbred mouse strains. Physiol Genomics (2010) 0.86
Function of the hemochromatosis protein HFE: Lessons from animal models. World J Gastroenterol (2008) 0.85
Does hemochromatosis predispose to celiac disease? A study of 29,096 celiac disease patients. Scand J Gastroenterol (2012) 0.85
Natural history of HFE simple heterozygosity for C282Y and H63D: a prospective 12-year study. J Gastroenterol Hepatol (2015) 0.85
Elevation in inflammatory serum biomarkers predicts response to trastuzumab-containing therapy. PLoS One (2012) 0.84
Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network. Am J Hum Genet (2015) 0.84
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosis. World J Gastroenterol (2012) 0.84
Paraoxonase-1 status in patients with hereditary hemochromatosis. J Lipid Res (2013) 0.82
The influence of iron status and genetic polymorphisms in the HFE gene on the risk for postoperative complications after bariatric surgery: a prospective cohort study in 1,064 patients. Patient Saf Surg (2011) 0.82
Magnetic Resonance Elastography and Other Magnetic Resonance Imaging Techniques in Chronic Liver Disease: Current Status and Future Directions. Gut Liver (2016) 0.82
Interrelationships between circulating gastrin and iron status in mice and humans. Am J Physiol Gastrointest Liver Physiol (2008) 0.82
The diagnosis and management of hereditary haemochromatosis. Clin Biochem Rev (2010) 0.82
Current and Future Burden of Chronic Nonmalignant Liver Disease. Clin Gastroenterol Hepatol (2015) 0.81
EMQN best practice guidelines for the molecular genetic diagnosis of hereditary hemochromatosis (HH). Eur J Hum Genet (2015) 0.81
Phenotypic characteristics and diagnoses of patients referred to an iron overload clinic. Dig Dis Sci (2009) 0.81
Novel loci affecting iron homeostasis and their effects in individuals at risk for hemochromatosis. Nat Commun (2014) 0.81
Quantitative trait locus linkage analysis in a large Amish pedigree identifies novel candidate loci for erythrocyte traits. Mol Genet Genomic Med (2013) 0.81
Liver enzymes serum levels in patients with chronic kidney disease on hemodialysis: a comprehensive review. Clinics (Sao Paulo) (2014) 0.80
IRon Overload screeNing tool (IRON): development of a tool to guide screening in primary care. Am J Hematol (2011) 0.80
Clinical guidelines: HFE hemochromatosis-screening, diagnosis and management. Nat Rev Gastroenterol Hepatol (2010) 0.80
Females Are Protected From Iron-Overload Cardiomyopathy Independent of Iron Metabolism: Key Role of Oxidative Stress. J Am Heart Assoc (2017) 0.80
Hypoparathyroidism and subclinical hypothyroidism with secondary hemochromatosis. Endocrinol Metab (Seoul) (2014) 0.79
On myocardial siderosis and left ventricular dysfunction in hemochromatosis. J Cardiovasc Magn Reson (2013) 0.79
Hereditary hemochromatosis: insights from the Hemochromatosis and Iron Overload Screening (HEIRS) Study. Hematology Am Soc Hematol Educ Program (2009) 0.78
Iron-overload injury and cardiomyopathy in acquired and genetic models is attenuated by resveratrol therapy. Sci Rep (2015) 0.78
A systems biology approach to iron metabolism. Adv Exp Med Biol (2014) 0.78
Evidence for the high importance of co-morbid factors in HFE C282Y/H63D patients cared by phlebotomies: results from an observational prospective study. PLoS One (2013) 0.78
Anti-obesity and pro-diabetic effects of hemochromatosis. Obesity (Silver Spring) (2014) 0.78
Management of elevated serum ferritin levels. Gastroenterol Hepatol (N Y) (2008) 0.78
Total ankle arthroplasty in patients with hereditary hemochromatosis. Clin Orthop Relat Res (2010) 0.78
Rare monogenetic syndromes in rheumatology practice. Clin Rheumatol (2009) 0.78
Association of Multiple Biomarkers of Iron Metabolism and Type 2 Diabetes: The EPIC-InterAct Study. Diabetes Care (2016) 0.77
The Southern French registry of genetic hemochromatosis: a tool for determining clinical prevalence of the disorder and genotype penetrance. Haematologica (2010) 0.77
The Regulation of Iron Absorption and Homeostasis. Clin Biochem Rev (2016) 0.76
Hereditary hemochromatosis (HFE) genotypes in heart failure: relation to etiology and prognosis. BMC Med Genet (2010) 0.76
Study of total stimulated saliva flow and hyperpigmentation in the oral mucosa of patients diagnosed with hereditary hemochromatosis. Series of 25 cases. Med Oral Patol Oral Cir Bucal (2012) 0.76
Unusual presentation of hemochromatosis as isolated metacarpophalangeal joint osteoarthritis: a case report. Hand (N Y) (2011) 0.76
HFE gene mutations increase the risk of coronary heart disease in women. Eur J Epidemiol (2010) 0.76
Diagnosis of hereditary hemochromatosis in the era of genetic testing. Dig Dis Sci (2012) 0.76
Erosive and inflammatory joint changes in hereditary hemochromatosis arthropathy detected by low-field magnetic resonance imaging. Rheumatol Int (2013) 0.76
Should HFE p.C282Y homozygotes with moderately elevated serum ferritin be treated? A randomised controlled trial comparing iron reduction with sham treatment (Mi-iron). BMJ Open (2015) 0.75
Effect of C282Y genotype on self-reported musculoskeletal complications in hereditary hemochromatosis. PLoS One (2015) 0.75
Transforming growth factor-β and toll-like receptor-4 polymorphisms are not associated with fibrosis in haemochromatosis. World J Gastroenterol (2013) 0.75
Whole genome sequencing of one complex pedigree illustrates challenges with genomic medicine. BMC Med Genomics (2017) 0.75
Iron-overload-related disease in HFE hereditary hemochromatosis. N Engl J Med (2008) 0.75
Re: PC Adams. Genetic testing for hemochromatosis: Diagnostic or confirmatory test for iron overload? Can J Gastroenterol Hepatol 2015;29(1):15-6. Can J Gastroenterol Hepatol (2015) 0.75
Diabetes in HFE Hemochromatosis. J Diabetes Res (2017) 0.75
Management of human factors engineering-associated hemochromatosis: A 2015 update. World J Hepatol (2016) 0.75
Hereditary hemochromatosis. Autops Case Rep (2015) 0.75
Quality of life utility values for hereditary haemochromatosis in Australia. Health Qual Life Outcomes (2016) 0.75
HFE genotyping in patients with elevated serum iron indices and liver diseases. Biomed Res Int (2015) 0.75
ironXS: high-school screening for hereditary haemochromatosis is acceptable and feasible. Eur J Hum Genet (2012) 0.75
Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23
Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet (2008) 15.43
Body-mass index and mortality among 1.46 million white adults. N Engl J Med (2010) 13.34
IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy. Nat Genet (2009) 13.03
Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ (2013) 9.38
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet (2007) 7.35
Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nat Genet (2009) 7.30
A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3. Nat Genet (2008) 6.26
Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet (2008) 6.22
Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med (2002) 6.19
Identification of seven new prostate cancer susceptibility loci through a genome-wide association study. Nat Genet (2009) 6.04
Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev (2007) 6.00
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) (2008) 5.82
Multiple loci with different cancer specificities within the 8q24 gene desert. J Natl Cancer Inst (2008) 5.82
Hemochromatosis and iron-overload screening in a racially diverse population. N Engl J Med (2005) 5.78
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol (2007) 5.20
Breast-cancer risk in families with mutations in PALB2. N Engl J Med (2014) 4.97
A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. Nat Genet (2010) 4.96
Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. J Natl Cancer Inst (2010) 4.54
The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Res (2004) 4.54
Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis. Lancet (2003) 4.49
Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood (2004) 4.40
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension (2003) 4.19
Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol (2005) 3.99
Multiple loci on 8q24 associated with prostate cancer susceptibility. Nat Genet (2009) 3.94
Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet (2009) 3.89
Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet (2011) 3.86
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Common sequence variants on 20q11.22 confer melanoma susceptibility. Nat Genet (2008) 3.79
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
Predictive genetic testing in minors for late-onset conditions: a chronological and analytical review of the ethical arguments. J Med Ethics (2012) 3.54
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 3.52
Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst (2002) 3.46
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer. Nat Genet (2011) 3.37
The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology (2008) 3.35
Incidence of new and changed nevi and melanomas detected using baseline images and dermoscopy in patients at high risk for melanoma. Arch Dermatol (2005) 3.24
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer. J Clin Oncol (2005) 3.19
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst (2013) 3.06
Multiple novel prostate cancer predisposition loci confirmed by an international study: the PRACTICAL Consortium. Cancer Epidemiol Biomarkers Prev (2008) 3.05
Identification of an intestinal heme transporter. Cell (2005) 3.05
Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet (2011) 3.03
Nomenclature of the finer branches of the biliary tree: canals, ductules, and ductular reactions in human livers. Hepatology (2004) 3.00
Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (2012) 2.98
A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature (2011) 2.96
Glycemic index and dietary fiber and the risk of type 2 diabetes. Diabetes Care (2004) 2.89